A Study Evaluating Quality of Life for Participants With Atrial Fibrillation (AF) Following a Bleed (EQUAL-AF)

Bristol-Myers Squibb50 enrolled

Overview

The purpose of this observational study is to identify participants with both minor and major bleeds as a result of anticoagulant treatment for AF and evaluating their QoL through both primary and secondary care settings.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Atrial Fibrillation

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com Inclusion Criteria: * Adult patients (\>= 18 years old) * Patients who can understand all study information and literature to provide fully informed consent * Atrial fibrillation (AF) as the primary diagnosis * Having a major or minor bleed up to a maximum of 30 days prior to point of enrolment * Receiving oral anticoagulation therapy for AF Exclusion Criteria: * Pregnant women * Patients with active cancer * Patients unable to consent for themselves * Patient on concomitant antiplatelet therapy

Locations (1)

Local Institution - 0001

Swansea, United Kingdom

Outcomes

Primary Outcomes

Distribution of characteristics of AF participants: Quality of life (QoL) data

Time frame: Up to 90 days

Distribution of characteristics of AF participants: Impact of the anticoagulation treatment

Time frame: Up to 90 days

Secondary Outcomes

Distribution of outcomes of AF participants: Timing of bleeding occurrence

Time frame: Up to 90 days

Distribution of outcomes of AF participants: Nature of the bleed

Time frame: Up to 90 days

Distribution of outcomes of AF participants: Current Bleeding treatment

Time frame: Up to 90 days

Distribution of outcomes of AF participants: Location of bleed

Time frame: Up to 90 days

Distribution of outcomes of AF participants: Documented cause of bleed

Time frame: Up to 90 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.